Item 5.07 Submission of Matters to a Vote of Security Holders.
At the 2022 annual meeting of Global Medical REIT Inc. (the "Company"), the
Company's stockholders: (i) elected the eight nominated directors to the
Company's Board of Directors, each to serve until the Company's 2023 annual
meeting of stockholders and until her or his successor is duly elected and
qualifies, (ii) approved, on an advisory basis, the compensation of the
Company's named executive officers, and (iii) ratified the appointment of
Deloitte & Touche LLP as the Company's independent registered public accounting
firm for the year ending December 31, 2022. The full results of the matters
voted on at the 2022 annual meeting of stockholders are set forth below:
Proposal 1 - Election of Directors:
Nominee for Director For Against Abstain Broker Non-Votes
Jeffrey M. Busch 42,941,919 2,277,422 150,259 10,577,481
Matthew Cypher 44,325,784 986,860 56,956 10,577,481
Ronald Marston 44,208,099 1,114,995 46,503 10,577,484
Roscoe Moore, Jr. 44,300,766 1,007,844 60,989 10,577,482
Henry E. Cole 44,918,473 402,754 48,374 10,577,480
Zhang Huiqi 45,081,576 236,932 51,091 10,577,482
Paula R. Crowley 45,101,550 213,263 54,787 10,577,481
Lori Wittman 44,333,467 982,056 54,077 10,577,481
Proposal 2 - Advisory Vote on Named Executive Officer Compensation:
For Against Abstain Broker Non-Votes
44,326,258 818,018 225,318 10,577,487
Proposal 3 - Ratification of Appointment of Independent Registered Public
Accounting Firm:
For Against Abstain Broker Non-Votes
55,785,212 84,797 77,072 0
Item 7.01 Regulation FD Disclosure.
On May 13, 2022, the Company updated a presentation concerning the Company on
its website, www.globalmedicalreit.com, on the "Investors" page. A copy of the
investor presentation is furnished as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein solely for purposes of this Item 7.01
disclosure. Such investor presentation shall not be deemed "filed" for any
purpose, including for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that Section. The information in this Item 7.01, as well as
Exhibit 99.1, shall not be deemed incorporated by reference into any filing
under the Securities Act of 1933, as amended, or the Exchange Act regardless of
any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Investor Presentation dated May 13, 2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses